Evidence map›Paper›PMID 37384546›Full record

ArticleRadiographics : a review publication of the Radiological Society of North America, Inc2023

Complications after Nephron-sparing Interventions for Renal Tumors: Imaging Findings and Management.

Aditi Chaurasia, Shiva Singh, Fatemeh Homayounieh, Nikhil Gopal, Elizabeth C Jones, W Marston Linehan, Paul B Shyn, Mark W Ball, Ashkan A Malayeri

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Radiographics : a review publication of the Radiological Society of North America, Inc, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Aditi ChaurasiaFrom the Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md (A.C., N.G., W.M.L., M.W.B.); Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Dr 1C352, Bethesda, MD 20892 (S.S., F.H., E.C.J., A.A.M.); and Division of Abdominal Imaging and Intervention, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (P.B.S.).
Shiva SinghFrom the Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md (A.C., N.G., W.M.L., M.W.B.); Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Dr 1C352, Bethesda, MD 20892 (S.S., F.H., E.C.J., A.A.M.); and Division of Abdominal Imaging and Intervention, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (P.B.S.).
Fatemeh HomayouniehFrom the Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md (A.C., N.G., W.M.L., M.W.B.); Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Dr 1C352, Bethesda, MD 20892 (S.S., F.H., E.C.J., A.A.M.); and Division of Abdominal Imaging and Intervention, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (P.B.S.).
Nikhil GopalFrom the Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md (A.C., N.G., W.M.L., M.W.B.); Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Dr 1C352, Bethesda, MD 20892 (S.S., F.H., E.C.J., A.A.M.); and Division of Abdominal Imaging and Intervention, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (P.B.S.).ORCID 0000-0002-4009-6778
Elizabeth C JonesFrom the Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md (A.C., N.G., W.M.L., M.W.B.); Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Dr 1C352, Bethesda, MD 20892 (S.S., F.H., E.C.J., A.A.M.); and Division of Abdominal Imaging and Intervention, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (P.B.S.).ORCID 0000-0003-4914-8180
W Marston LinehanFrom the Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md (A.C., N.G., W.M.L., M.W.B.); Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Dr 1C352, Bethesda, MD 20892 (S.S., F.H., E.C.J., A.A.M.); and Division of Abdominal Imaging and Intervention, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (P.B.S.).
Paul B ShynFrom the Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md (A.C., N.G., W.M.L., M.W.B.); Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Dr 1C352, Bethesda, MD 20892 (S.S., F.H., E.C.J., A.A.M.); and Division of Abdominal Imaging and Intervention, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (P.B.S.).ORCID 0000-0003-0538-2151
Mark W BallFrom the Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md (A.C., N.G., W.M.L., M.W.B.); Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Dr 1C352, Bethesda, MD 20892 (S.S., F.H., E.C.J., A.A.M.); and Division of Abdominal Imaging and Intervention, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (P.B.S.).
Ashkan A MalayeriFrom the Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md (A.C., N.G., W.M.L., M.W.B.); Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, 10 Center Dr 1C352, Bethesda, MD 20892 (S.S., F.H., E.C.J., A.A.M.); and Division of Abdominal Imaging and Intervention, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (P.B.S.).ORCID 0000-0002-4442-7343
National Institutes of Health · USNational Institutes of Health Clinical Center · USBrigham and Women's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The two primary nephron-sparing interventions for treating renal masses such as renal cell carcinoma are surgical partial nephrectomy (PN) and image-guided percutaneous thermal ablation. Nephron-sparing surgery, such as PN, has been the standard of care for treating many localized renal masses. Although uncommon, complications resulting from PN can range from asymptomatic and mild to symptomatic and life-threatening. These complications include vascular injuries such as hematoma, pseudoaneurysm, arteriovenous fistula, and/or renal ischemia; injury to the collecting system causing urinary leak; infection; and tumor recurrence. The incidence of complications after any nephron-sparing surgery depends on many factors, such as the proximity of the tumor to blood vessels or the collecting system, the skill or experience of the surgeon, and patient-specific factors. More recently, image-guided percutaneous renal ablation has emerged as a safe and effective treatment option for small renal tumors, with comparable oncologic outcomes to those of PN and a low incidence of major complications. Radiologists must be familiar with the imaging findings encountered after these surgical and image-guided procedures, especially those indicative of complications. The authors review cross-sectional imaging characteristics of complications after PN and image-guided thermal ablation of kidney tumors and highlight the respective management strategies, ranging from clinical observation to interventions such as angioembolization or repeat surgery.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsHumansKidneyNeoplasm Recurrence, LocalNephrons

Identifiers

PMID37384546
PMCPMC10323228
OpenAlexW4382632652

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.